PPARGC1A and Huntington disease: The complex interplay between genetic factors, including mHTT, PGC-1α, BDNF, and ADORA2A, demonstrates the intricate relationship between genetic predisposition and vascular pathology, necessitating a more holistic approach to HD treatment.